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Induction of a subpopulation of suppressor cells by a single blood
transfusion. Blood transfusion induces immunosuppression by a mech-
anism which is probably multifactorial and, in large part, obscure. In
this study cellular immune suppression was examined in patients with
end-stage renal disease (ESRD) following a single blood transfusion
(BT). OKT8 cells proliferated within four hours, their count increasing
significantly, and reached their peak after four days. Since OKT4 cells
tended to decrease, the OKT4/OKT8 ratio declined significantly from
the fourth day. Evidence in support of the above results is offered in
studies on ability of concanavalin A reagent (ConA)-activated T cells to
form autorosettes with human red blood cells (RBC); these T cells have
been shown to function as suppressor effector cells. Autorosetting cells
(RFC) proliferated in a similar pattern to OKT8 cells. Moreover, the
percentage of rise at one and two weeks of OKT8 and RFC correlated
directly, suggesting that the proliferating OKT8 cells are in large part
a subset of suppressor cells. Functional studies were performed to
establish the suppressor activity of T cells before and at various times
after blood transfusion. A significant increase in T cell ConA-induced
suppressor activity was found one week after BT, peaking at two weeks
following BT. Monocytes increased significantly from day 4 following
BT, but prostaglandin E2 (PGE2) started to rise immediately, peaking at
day 4. PGE2 might induce suppression by induction of suppressor cells
or by direct suppression of interleukin-2. Both monocytes and suppres-
sor cells respond immediately, but they probably induce suppression
most effectively four days or more after BT.
Blood transfusion (BT) has been found to improve renal
allograft survival [1]. This observation has been amply con-
firmed by subsequent studies [2, 31, however, the mechanisms
implicated in mediating this beneficial effect remain obscure.
Several mechanisms have been suggested, including: induction
of suppressor cells [4]; induction of anti-idiotypic antibody
production [51; inactivation of alloreactive clones of cells [61
and increased production of prostaglandin E2 (POE2) [7]. Both
T lymphocytic and monocytic suppressive activities were re-
ported following BT [4], and interaction between these two
populations was also suggested [81. However the longitudinal
phenotypic and functional manifestations of suppressor cells
were not defined. Recently, we have shown an additional
pathway of immune suppression exhibited by reduction of
secretion of various cytokines following a single BT [9]. The
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present study was undertaken to further elucidate the cellular
suppressive mechanism by sequentially evaluating the cellular
response after a single BT in humans. Blood was withdrawn
from patients with end-stage renal disease (ESRD) before BT
and four hours, four, seven and 14 days after BT. Changes in B
and T lymphocytes as well as OKT4, OKT8 and Tac positive
cells were determined. In addition, the response of a suppressor
T cell subset, defined by the ability to form rosettes (RFC) with
autologous red blood cells (RBC) [10] was determined. By this
technique it is possible to exclusively separate a subpopulation
of suppressor cells [11]. Monocyte count and the simultaneous
secretion of PGE2 by peripheral blood mononuclear cells
(MNC) was measured. Finally, functional studies on T cells
from patients were performed before BT, and seven and 14 days
after BT, in order to establish their suppressor activity.
Methods
Subjects
Twelve patients with chronic renal failure who were on
maintenance dialysis treatment were studied. Seven of them
were men and five were women. Their age range was 23 to 76
years (50 6 years, mean SE). The renal diseases leading to
end-stage renal failure included: chronic glomerulonephritis (3),
interstitial nephropathy (2), reflux nephropathy (2), diabetic
nephropathy (2), atherosclerotic renal artery occlusion (1),
rapidly progressive glomerulonephritis (1), unilateral renal
agenesis (1). Ten of the subjects were on hemodialysis and two
were on continuous ambulatory peritoneal dialysis (CAPD).
They received dialysis treatment for four months to 8.5 years
(3.1 0.8 years, mean SE). The patients were not transfused
for at least three months prior to the study. At the beginning of
this study, patients were transfused with one unit of packed
cells of 200 to 250 ml. Blood for assays was withdrawn into
heparinized tubes in the morning, immediately before the
hemodialysis except for the blood taken after the BT. Each
patient was tested twice before being transfused.
Reagents
Concanavalin A (ConA) was purchased from Miles Yeda
(Rehovot, Israel). Phytohemagglutinin (PHA-M) was from
Difco Laboratories (St. Louis, Missouri, USA); fetal calf serum
(FCS) was from Maagar (Beit Haemek, Israel). Enriched RPMI
1640 was comprised of RPMI 1640 (Oibco Labs, Grand Island,
New York, USA) and was supplemented with 10% FCS, 2 mM
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L-glutamine, 10 m nonessential amino acids, 3 m sodium
pyruvate, 5 X i0 M 2-ME, 100 lU/mI penicillin, and 100 j.tg/ml
streptomicin.
Cell preparation
Peripheral blood mononuclear cells (MNC) were isolated
following Ficoll-Hypaque gradient centrifugation. The isolated
MNC were washed and suspended in enriched RPMI-1640 at a
concentration of 106/ml.
Surface marker determination
Peripheral blood lymphocytes were analyzed for the presence
of several surface antigens using monoclonal antibodies: CD3
(OKT3), CD4 (OKT4), CD8 (OKT8), CD19 (anti-B4) and CD25
(anti-Tac). The method is based on an immunoperoxide tech-
nique. Lymphocytes, labelled with monoclonal antibodies
(MoAb) and reacting with peroxidase, were stained and
counted using the Direct Cytometry Option available for Tech-
nicon H-l Systems. Briefly, an aliquot of 0.1 ml whole blood
sample was first reacted with the appropriate MoAb reagent,
followed by erythrocyte lysis and fixation. Biotinylated IgG
reagent was used to amplify the response from the subsequently
labelled avidin-peroxidase reagent, and the labelled lympho-
cytes were stained in a specific amount of hydrogen peroxide
plus 4-chloro-l-naphthol in HEPES buffer, then counted by the
Technicon H-l System.
ConA activation for autorosetteformation
MNC, 2 x 106, were cultured in 110 x 16 mm test tubes
(Nunc) in 2 ml RPMI 1640 containing 10% FCS and 10 p,g/ml
ConA. The cells were cultured for 60 hours at 37°C in a
humidified atmosphere containing 7.5% CO2 in air, and then
harvested by centrifugation.
Autorosette formation and fractionation
ConA-activated MNC were rosetted with autologous red
blood cells (RBC) by a modification of the technique of Kaplan
[12], as described by Palacios et al [13]. Briefly, 2 x 106 viable,
ConA-stimulated MNC were washed twice with phosphate
buffered saline (PBS), suspended in 0.2 ml PBS and mixed with
108 autologous RBC in a volume of 0.5 ml PBS (stored from day
0 in Alsever's solution) and 0.2 ml FCS. The cells were mixed
thoroughly and incubated at 37°C for 10 minutes. The cell
mixture was then centrifuged at 150 g for five minutes, and the
tubes were kept in ice for two hours to permit the formation of
autorosettes. Aliquots of cells from the pellet were placed in a
hemocytometer, 300 lymphocytes were counted, and the per-
centage of RFC calculated. A lymphocyte with three or more
attached RBC was considered a rosette.
Quantitation of PGE2
Supernatants from 48-hour PHA-stimulated MNC (1 x 106/
ml) were collected and the POE2 concentration was measured
by a competitive binding radioimmunoassay (Clinical Assays,
Travenol-Genetech, Cambridge, Massachusetts, USA).
Fur j/ication ofT cells and monocytes
Peripheral blood mononuclear cells were isolated by centrif-
ugation on a Ficoll-Hypaque gradient. T cells and monocytes
were sçparated from the MNC as described below. Briefly,
spontaneous rosette formation between the MNC and sheep
erythrocytes (SRBC) was performed. The rosetted cells were
separated on another Ficoll-Hypaque gradient from the non-
rosetting cells, and was then further purified by repeated rosette
formation with SRBC and subsequent density gradient centrif-
ugation. The doubly-purified rosetting cell population was re-
covered after lysis of SRBC by a Tris-buffered ammonium
chloride solution. This population was referred to as T cells as
determined by rerosetting and reactivity with OKT3 monoclo-
nal antibodies. Monocytes were obtained by collecting the cells
adhering firmly to the dishes. More than 95% of these cell
preparations were monocytes, as judged by morphology after
Giemsa staining and by reactivity with 0KM 1 monoclonal
antibodies.
Assay of suppressor cell function
Suppressor T cells were generated by ConA activation in a
first culture as described above. These cells were added to
responder cells in a second assay system that was stimulated
with either PHA or allogeneic cells (MLR). Responder cells
were obtained three days later from another individual. The
same individual provided the responder cells for all subsequent
assays. In detail, 3 x 106 T cells were incubated in 3 ml culture
medium (RPMI-1640) supplemented with 10% FCS with 30 sg
ConA (ConA-activated T cells) or without ConA (nonactivated
control T cells) at 37°C in a humidified incubator. To both
nonactivated and ConA activated cultures, 0.2 x 106 mitomycin
treated monocytes were added. Sixty hours later, the cells were
harvested, washed three times, treated with mitomycin, and
then tested for their suppressive ability in the second assay
culture. A total of 1 x l0 mitomycin-treated T cells from the
first culture were added to the second assay cultures of I x l0
responder T cells + 3 x l0 mitomycin-treated monocytes. The
responder T cells were either stimulated with 1 x l0 mitomy-
cm-treated allogeneic cells or with 100 tg/ml PHA. All cultures
were performed in triplicate of 200 j.d in microtiter plates and
incubated for 96 or 120 hours (PHA stimulation or MLR,
respectively) at 37°C in a 8.5% C02/9l .5% air humidified
environment. The proliferative response was measured by
incorporation of 3H-TdR during the last 20 hours of culture.
The degree of suppression was calculated by the following
formula:
Percent suppression =
1— [mean cpm of stimulated cultures
containing nonactivated T cells
— mean cpm of unstimulated cultures
containing nonactivated T cells]
Statistical analysis
Data are presented as mean SE. Comparisons within the
groups were performed with the paired t-test. Pearson's linear
regression analysis was used for correlations between groups.
The two tailed F C 0.05 was considered significant.
[mean cpm of stimulated cultures
containing ConA-activated T cells
— mean cpm of unstimulated cultures
containing ConA-activated T ceIlsi
x 100
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Table 1. Cellular response to blood transfusion
Cells Before BT
After BT
4 hours 4 days 7 days 14 days
WBC count mm3
Lymphocytes %
T cells % (OKT3)
B cells % (B4)
8517 627
24.8 1.7
63.1 2.6
8.1 1.4
9600 1083
19.2 l.6
60.7 2.8
9.8 2.1
7810 526
27.4 2.3
67.8 2.1"
6.2 0.9
8567 572
24.3 1.8
60.1 2.1
7.9 0.8
8370 898
23.9 2.2
62.4 2.4
7.8 1.7
Abbreviation is: BT = blood transfusion
a p <ooi b P < 0.05 vs. before BT
0
30
25
20
15
10
Time after BT
0U-
30
25
20
15
10
Fig. 1. The effect ofBTon OKT8 cells. * <0.001, <0.005, ***P Fig 2
<0.01 vs. before BT.
Results
The responses of white blood cells (WBC), lymphocytes,
OKT3 cells and B cells (B4) are given in Table 1. The WBC
count did not change during two weeks following BT. The total
lymphocyte count decreased significantly within four hours but
returned to basal levels in the three subsequent measurements.
B cells did not change during the two weeks following BT. As
for T lymphocytes, the percent of OKT3 cells (Table 1) was
not different from basal level four hours after BT; it rose
significantly four days after BT and returned to baseline values
one and two weeks after BT.
OKT4. The percentage of OKT4 cells was 37.1 3.04
before BT. At four hours, four and 14 days following BT, it was
34.9 2.5%, 33.5 1.8%, and 32.3 2.9%, respectively. This
showed a tendency to decrease which did not reach statistical
significance. Only at one week after BT was the level of OKT4
cells significantly decreased to 29.0 2.4% (P < 0.05).
OKT8. OKT8 cells (Fig. 1) rose immediately from 17.0
2.1% to 21.4 2.5% four hours later (P < 0.005). It reached
24.8 2.4% on the fourth day after BT (P < 0.001) and stayed
elevated throughout the two weeks of study. The rise in OKT8
with either no change or a decrease in OKT4 cells led to a
significant decrease in the OKT4/OKT8 ratio by day 4 after BT,
from 2.4 0.5 to 1.6 0.2 (P < 0.05). This reduced ratio was
sustained until the end of the study.
RFC. Autorosette forming cells proliferated following BT
(Fig. 2). Within four hours their count rose form 14.9 0.9% to
21.8 1.2% (P < 0.001), by four days it reached 24.7 1.3%
(P < 0.001), by one week 23.9 1.3% (P < 0.001), and by two
weeks 21.8 1.1% (P < 0.001).
Time after BT
The effect of BT on RFC. *p < 0.001 vs. before BT.
The response of OKT8 positive cells correlated with the
response of RFC. Figure 3 illustrates the correlation between
the rise in OKT8 positive cells and RFC by seven days after BT.
A direct correlation was found (r = 0.770, P < 0.01). The
response at two weeks following BT also showed positive
correlation between OKT8 and RFC proliferation (r = 0.602,
P < 0.05).
ConA -induced suppressor activity
In these experiments the suppressor cells were obtained from
patients before and following BT, and the responder cells were
obtained from a healthy volunteer. T lymphocytes from patients
before BT manifested a degree of suppression which amounted
Before 4hr 4day 7day 14 day Before 4hr 4day 7day 14 day
15
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9
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Fig. 3. The correlation between the rise in RFC and OKT8 cells
following BT.
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Fig. 4. The effect of BT on suppressor T cell activity. Purified T cells
were incubated for 60 hours with or without ConA in a first culture.
These cells were introduced into freshly prepared purified responder T
cells in a second assay culture stimulated with either MLR allogeneic
cells () or PHA (). *JJ < 0.001 vs. pre-BT, p < 0.01 2 weeks vs. 1
week.
to 53.0 5.4% and 50.0 5.2% for T cell-proliferative response
to MLR and to PHA, respectively (Fig. 4). A significant
increase in suppressor activity was noted for both reactions one
week after BT: 69.0 4.2% (P < 0.001) and 68.0 5.1% (P
< 0.001) for MLR and PHA, respectively. An additional
increase in suppressor activity was noted two weeks after BT.
This increased suppressor activity was observed either when
suppression was measured by the response of T cells to
allogeneic cells, 79.1 3.9% (P <0.001) or to PHA, 80.2
3,4% (P < 0.001). The suppression two weeks following BT was
significantly greater than the suppression measured one week
after BT, both in response to allogeneic cells (P < 0.01) or to
PHA (P < 0.01).
Tac. The response of Tact cells to BT is depicted in Figure
5. They proliferated immediately within four hours. Their
percentage increased from 17.3 2.3% to 21.8 2.3%,
however, this increase was not significant. No data was ob-
tained for day 4 due to technical difficulties. On day 7 post-BT
Tack cells rose to 25.9 2.4% (P < 0.01), and by two weeks
this level was sustained at 23.9 3.0% (P <0.05).
Monocytes. The response of monocytes measured by cell
count and secretion rate of PGE2 is illustrated in Figure 6.
Monocyte count increased significantly on the fourth day after
BT from 4.8 0.4% to 6.3 0.5% (P < 0.05). It decreased later
on to levels not different from the baseline count. PGE2 doubled
within four hours from 239 140 to 413 216 pg/0.1 ml (one
tail, P < 0.05). It then increased by the fourth day after BT to
821 325 pg/O.1 ml (P < 0.05) and maintained that level one
week following BT. Two weeks after BT it decreased to basal
level.
Discussion
There is considerable evidence to suggest that BT can induce
enhancement or active immunologic unresponsiveness to do-
nors' alloantigens in humans. This immunologic unresponsive-
ness could be induced in part by suppressor T cells. Lenhard et
al [4] demonstrated suppressor activity following BT in humans
using the concanavalin A enhancement method. They sug-
gested that in the immediate post-transfusion period monocytes
act as nonspecific suppressor cells, and that after 14 days T
suppressor cells activity increases [4]. Smith et al [14], using a
similar technique, described immunosuppression three weeks
after BT. However, neither Lenhard et al [4, 15] nor Smith et al
[141 could detect any change in T cell subpopulation.
The present study was designed to define T cell subpopula-
tion response to a single BT. The most impressive change was
noted in OKT8 positive cells whose percentage rose signifi-
cantly within four hours and continued to rise until the fourth
day, after which it levelled off. The elevated level of OKT8
positive cells was sustained throughout the remainder of the
study, leading to a decreased OKT4/OKT8 positive cells ratio
from day 4 to the end of the study period.
These results differ from those of Lenhard et al and Smith et
al. They correspond to studies suggesting a rise in OKT8 with
a decrease in OKT4/OKT8 ratio in hypertransfused patients
with thalassemia [16], sickle cell anemia [17] or in transfused
uremic patients [18]. The difference in results between the
present study and the studies of Lenhard et al and Smith et al
could be attributed to different techniques for determining
subpopulations.
To better define which subpopulation of OKT8 cells prolif-
erates following BT, we evaluated autorosette forming cells
(RFC) which represent a unique subset of suppressor cells.
Following BT there was a rise which correlated positively
with the rise in OKT8 cells one and two weeks after BT. This
may suggest that the rise in OKT8 positive cells is in large part
due to proliferation of RFC. The increase in the percent of
OKT8 cells and in the percent of RFC was accompanied by an
increase in functional suppressor activity observed at one week
after BT, and even more so at two weeks following BT. This
suppressor activity was manifested in the response of T cells to
both allogeneic cells in the MLR and in the mitogenic response
to PHA. Although we cannot conclude that the increase in
suppressor function is necessarily related to an increase in the
substantial numbers of individual suppressor effector cells
rather than to their increased function, or that it is the result of
both, there is, nevertheless, a very marked overall increase in
suppressor activity by T cells following a single blood transfu-
sion.
Tack cells proliferated following BT in a pattern similar to the
C0
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Fig. 5. The
before BT.
Before 4 hr 7 days 14 days
Time after BT
effect of BT on Tact cells. *J) < 0.005, < 0.05 vs.
100
1 week 2 weeks
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Fig. 6. The effect of BT on monocyte
number and secretion of PGE2. Columns
represent monocytes; PGE2 concentration
(pgIO.l ml) is depicted by numbers above
the columns. *p < 0.05 vs. before BT.
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